A no good, very bad week for the FDA

Off Biotech, Congress, D.C. Diagnosis, drug pricing, FDA, Human Health, Life Sciences, Medicine, monkeypox, Science and Research, White House

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Dietary supplements, really, really aren’t regulated, huh?

Read the rest…

Read Original Article: A no good, very bad week for the FDA »

About The Author